Research for mesothelioma generally begins in a laboratory and initial tests typically involve lab mice. If early experiments are deemed successful and all parameters of the research meet federally-imposed guidelines for use on humans, the treatment is deemed safe for trial.
Clinical trials are designed to test new medications, treatments and therapies on patients who have a particular disease. Most oncologists, especially those who specialize in the treatment of mesothelioma, will be well-versed on what clinical trials are available and can easily determine who qualifies for what trial. Patients considering participation in clinical trials should know some basic information before making their decision.
Many patients diagnosed with mesothelioma may be interested in current clinical trials and Asbestos.com offers an informative packet containing the most up-to-date information about studies and various treatment options. Patients and family members who wish to receive a complimentary comprehensive packet may fill out this form to receive their packet overnight.
Clinical trials may test new forms of traditional treatments such as chemotherapy or new ways to deliver radiation to the affected area of the body. In the past, new medications with fewer side effects have emerged triumphant from clinical trials and some mesothelioma patients have seen significant improvement in their quality of life.
Some clinical trials address other potential treatments outside the traditional, including immunotherapy, gene therapy and photodynamic therapy. Those who participate in these trials need to be willing to step out of the box and try something that might not be proven to help, but most agree that participating in clinical trials are worth a try.
Clinical trials are designed to test new medications, treatments and therapies on patients who have a particular disease. Most oncologists, especially those who specialize in the treatment of mesothelioma, will be well-versed on what clinical trials are available and can easily determine who qualifies for what trial. Patients considering participation in clinical trials should know some basic information before making their decision.
Many patients diagnosed with mesothelioma may be interested in current clinical trials and Asbestos.com offers an informative packet containing the most up-to-date information about studies and various treatment options. Patients and family members who wish to receive a complimentary comprehensive packet may fill out this form to receive their packet overnight.
Clinical trials may test new forms of traditional treatments such as chemotherapy or new ways to deliver radiation to the affected area of the body. In the past, new medications with fewer side effects have emerged triumphant from clinical trials and some mesothelioma patients have seen significant improvement in their quality of life.
Some clinical trials address other potential treatments outside the traditional, including immunotherapy, gene therapy and photodynamic therapy. Those who participate in these trials need to be willing to step out of the box and try something that might not be proven to help, but most agree that participating in clinical trials are worth a try.
Sources:
http://www.cancer.org/docroot/CRI/content/CRI_2_4_4X_Clinical_Trials_29.asp?sitearea=
http://www.cancer.gov/cancertopics/types/malignantmesothelioma
http://www.atsdr.cdc.gov/asbestos/medical_community/case_studies/
Dodson, R. and Hammar, S. Asbestos: Risk Assessment, Epidemiology, and Health Effects. Taylor & Francis: Boca Raton. 2006.
Parker, J. and Parker, P. Mesothelioma. ICON Health Publications: San Diego. 2004.
http://www.cancer.org/docroot/CRI/content/CRI_2_4_4X_Clinical_Trials_29.asp?sitearea=
http://www.cancer.gov/cancertopics/types/malignantmesothelioma
http://www.atsdr.cdc.gov/asbestos/medical_community/case_studies/
Dodson, R. and Hammar, S. Asbestos: Risk Assessment, Epidemiology, and Health Effects. Taylor & Francis: Boca Raton. 2006.
Parker, J. and Parker, P. Mesothelioma. ICON Health Publications: San Diego. 2004.
0 comments